• LAST PRICE
    106.4200
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (0.0752%)
  • Bid / Lots
    104.3200/ 1
  • Ask / Lots
    113.8500/ 1
  • Open / Previous Close
    105.5700 / 106.3400
  • Day Range
    Low 105.0100
    High 106.7400
  • 52 Week Range
    Low 102.0000
    High 133.9000
  • Volume
    3,920,050
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesZBH
Zimmer Biomet Holdings Inc
21.7B
22.2x
---
United StatesAVTR
Avantor Inc
18.8B
51.0x
---
United StatesSTE
STERIS plc
23.6B
41.4x
+9.33%
United StatesCOO
Cooper Companies Inc
22.1B
61.5x
+27.07%
United StatesWST
West Pharmaceutical Services Inc
22.6B
43.8x
+23.79%
United StatesALGN
Align Technology Inc
19.2B
42.9x
+3.39%
As of 2024-09-21

Company Information

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.

Contact Information

Headquarters
345 E Main StWARSAW, IN, United States 46580-2746
Phone
574-267-6131
Fax
302-636-5454

Executives

Independent Chairman of the Board
Christopher Begley
President, Chief Executive Officer, Director
Ivan Tornos
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Suketu Upadhyay
President - Americas
Mark Bezjak
President - Europe, Middle East and Africa
Wilfred Van Zuilen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$21.7B
Revenue (TTM)
$7.5B
Shares Outstanding
203.7M
Dividend Yield
0.90%
Annual Dividend Rate
0.9600 USD
Ex-Dividend Date
09-30-24
Pay Date
10-31-24
Beta
1.03
EPS
$4.80
Book Value
$60.70
P/E Ratio
22.2x
Price/Sales (TTM)
2.9
Price/Cash Flow (TTM)
11.0x
Operating Margin
16.45%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.